Transform Weight Loss

Transform Weight Loss operates in Portland, Oregon, under the clinical direction of Dr. Peter Billing, a Mayo Clinic-trained physician who applies evidence-based protocols to medical weight management. The clinic structures its programs around GLP-1 receptor agonist peptides—specifically tirzepatide and semaglutide—which have demonstrated efficacy in clinical trials for appetite regulation and metabolic optimization. Dr. Billing's training at Mayo Clinic informs the clinic's diagnostic approach, which includes metabolic panel analysis, body composition assessment, and individualized dosing strategies that account for patient response and tolerance thresholds.

The clinic's peptide protocols center on tirzepatide, a dual GIP/GLP-1 receptor agonist, and semaglutide, a selective GLP-1 agonist, both administered via subcutaneous injection on weekly schedules. Treatment plans at Transform Weight Loss begin with baseline laboratory work to evaluate thyroid function, insulin sensitivity, and lipid profiles, followed by structured titration phases that minimize gastrointestinal side effects while optimizing weight reduction outcomes. Dr. Billing monitors patient progress through regular follow-up appointments that track weight trends, adjust peptide dosages, and address barriers to adherence. The clinic also integrates nutritional counseling and behavioral modification strategies to support long-term metabolic health beyond peptide therapy alone.

Dr. Billing's clinical background includes training in internal medicine and obesity medicine, with a focus on pharmacologic interventions for metabolic dysfunction. His approach emphasizes patient education on the mechanisms of GLP-1 and GIP receptor activation, including effects on gastric emptying, insulin secretion, and central appetite pathways. Patients at Transform Weight Loss receive detailed explanations of expected outcomes, potential side effects such as nausea or injection site reactions, and contraindications including personal or family history of medullary thyroid carcinoma. The clinic maintains a low patient-to-provider ratio to ensure Dr. Billing can conduct thorough consultations and adjust treatment plans based on individual metabolic responses.

Transform Weight Loss offers hybrid consultation models, with in-person visits available at the Portland clinic and telehealth appointments for patients in Oregon and Washington. Initial consultations typically last 45 to 60 minutes and include a comprehensive review of medical history, current medications, and weight loss goals. Patients receive detailed injection training, either in-person or via video demonstration, along with written protocols for peptide storage, reconstitution if applicable, and injection technique. Follow-up appointments occur every four weeks during the titration phase, then transition to every eight to twelve weeks once patients reach maintenance dosing. The clinic coordinates with local laboratories in Portland and throughout Oregon and Washington to facilitate convenient blood work and monitoring.

What distinguishes Transform Weight Loss in the Portland market is its exclusive focus on peptide-based weight management rather than a broad wellness menu, allowing Dr. Billing to maintain deep expertise in GLP-1 and GIP pharmacology. The clinic does not offer surgical weight loss referrals or meal replacement products, instead concentrating clinical resources on optimizing peptide therapy outcomes through precise dosing and metabolic monitoring. Patients who require cosmetic treatments for skin laxity or body contouring following significant weight loss can access these services through the clinic's aesthetic division, creating a continuum of care that addresses both metabolic and cosmetic concerns. Transform Weight Loss accepts self-pay patients and provides transparent pricing structures for peptide therapy programs, with costs disclosed during the initial consultation based on the selected peptide and anticipated treatment duration.